These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 3863968)

  • 1. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
    Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
    Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical utility of tumor markers in gastric and colon cancer].
    Ogawa K; Naritaka Y; Koyama N; Ohtani Y; Kawata H; Yagawa H; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
    Sekikawa K
    Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
    Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of CA 19-9 in tumor after-care in stomach and colorectal cancer].
    Safi F; Rappenecker B; Roscher R; Beger HG
    Med Klin (Munich); 1986 Jan; 81(1):12-4. PubMed ID: 3466002
    [No Abstract]   [Full Text] [Related]  

  • 10. [CA-50 in serum of patients with carcinoma. Clinical experiences with a new tumor marker].
    Bruhn HD; Broers H; Euler H; Everding A; Feller AC; Hedderich J; Jostarndt L; Jooss B; Zurborn KH; Löffler H
    Dtsch Med Wochenschr; 1986 Aug; 111(34):1267-72. PubMed ID: 3461933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
    Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
    J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer.
    Talbot RW; Nagorney DM; Pemberton JH; Wieand HS; Ritts RE
    Cancer Res; 1989 Feb; 49(3):542-3. PubMed ID: 2910474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of postoperative determination of CEA in carcinoma of the large intestine].
    Florianello F; Gorla C; Biraghi T; Caron R; Scortecci V
    Minerva Med; 1986 Apr; 77(18):739-41. PubMed ID: 3714087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative determination of carcinoembryonic antigen and gastrointestinal antigen in neoplastic colorectal pathology. Case contributions].
    Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
    Minerva Chir; 1987 Jun; 42(12):1037-43. PubMed ID: 3476864
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
    Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
    Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pretreatment evaluation of CA 72.4 in patients with carcinoma of the stomach (0-IV stage) versus CEA, TPA, CA 19-9, FER].
    Buda F; Aragona P; Giani G; Sisto R; Di Nardo G; Binotto F; Gangemi P; De Zerbi T; Gentile G; Papadia A
    G Ital Oncol; 1989; 9(2-3):67-72. PubMed ID: 2767730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of preoperative carcinoembryonic antigen in stomach and colorectal cancer.
    Staab HJ; Anderer FA; Brummendorf T; Fischer R
    Cancer Detect Prev; 1983; 6(1-2):149-53. PubMed ID: 6883376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer].
    Yukawa H; Kono N; Taniguchi K; Ieda K; Ono K; Yamamoto S; Koh K; Ohta M; Hayashido M; Yamaguchi K
    Nihon Geka Hokan; 1984 Mar; 53(2):433-6. PubMed ID: 6508467
    [No Abstract]   [Full Text] [Related]  

  • 20. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.